These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. de Castria TB; da Silva EM; Gois AF; Riera R Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842 [TBL] [Abstract][Full Text] [Related]
3. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. Felip E; Rosell R; Maestre JA; Rodríguez-Paniagua JM; Morán T; Astudillo J; Alonso G; Borro JM; González-Larriba JL; Torres A; Camps C; Guijarro R; Isla D; Aguiló R; Alberola V; Padilla J; Sánchez-Palencia A; Sánchez JJ; Hermosilla E; Massuti B; J Clin Oncol; 2010 Jul; 28(19):3138-45. PubMed ID: 20516435 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224 [TBL] [Abstract][Full Text] [Related]
5. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC). Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086 [TBL] [Abstract][Full Text] [Related]
6. Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial. Quoix E; Audigier-Valette C; Lavolé A; Molinier O; Westeel V; Barlesi F; Le Treut J; Pichon E; Dauba J; Otto J; Moreau L; Madelaine J; Dumont P; Margery J; Debieuvre D; Renault PA; Pujol JL; Langlais A; Morin F; Moro-Sibilot D; Souquet PJ Eur J Cancer; 2020 Oct; 138():193-201. PubMed ID: 32898792 [TBL] [Abstract][Full Text] [Related]
7. Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group. Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Manzione L; Bilancia D; Cioffi R; Maiorino L; De Cataldis G; Belli M; Micillo E; Mascia V; Massidda B; Lorusso V; De Lena M; Carpagnano F; Contu A; Pusceddu G; Comella G J Clin Oncol; 1999 Aug; 17(8):2316-25. PubMed ID: 10561293 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer. Detterbeck FC; Socinski MA; Gralla RJ; Edelman MJ; Jahan TM; Loesch DM; Limentani SA; Govindan R; Zaman MB; Ye Z; Monberg MJ; Obasaju CK J Thorac Oncol; 2008 Jan; 3(1):37-45. PubMed ID: 18166839 [TBL] [Abstract][Full Text] [Related]
9. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. Kubota K; Kawahara M; Ogawara M; Nishiwaki Y; Komuta K; Minato K; Fujita Y; Teramukai S; Fukushima M; Furuse K; Lancet Oncol; 2008 Dec; 9(12):1135-42. PubMed ID: 19013107 [TBL] [Abstract][Full Text] [Related]
10. Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial. Ferry D; Billingham L; Jarrett H; Dunlop D; Woll PJ; Nicolson M; Shah R; Thompson J; Spicer J; Muthukumar D; Skailes G; Leonard P; Chetiyawardana AD; Wells P; Lewanski C; Crosse B; Hill M; Gaunt P; O'Byrne K Eur J Cancer; 2017 Sep; 83():302-312. PubMed ID: 28780466 [TBL] [Abstract][Full Text] [Related]
11. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197 [TBL] [Abstract][Full Text] [Related]
12. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. Pisters KM; Vallières E; Crowley JJ; Franklin WA; Bunn PA; Ginsberg RJ; Putnam JB; Chansky K; Gandara D J Clin Oncol; 2010 Apr; 28(11):1843-9. PubMed ID: 20231678 [TBL] [Abstract][Full Text] [Related]
13. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer]. Liu L; Wang XW; Li L; Zhang X; Zhang WD; Yu XJ Ai Zheng; 2006 Aug; 25(8):990-4. PubMed ID: 16965680 [TBL] [Abstract][Full Text] [Related]
14. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Rivera MP; Detterbeck FC; Socinski MA; Moore DT; Edelman MJ; Jahan TM; Ansari RH; Luketich JD; Peng G; Monberg M; Obasaju CK; Gralla RJ Chest; 2009 Jun; 135(6):1588-1595. PubMed ID: 19188545 [TBL] [Abstract][Full Text] [Related]
15. Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial). Hu L; Liang G; Yuliang W; Bingjing Z; Xiangdong Z; Rufu X Trials; 2013 Feb; 14():45. PubMed ID: 23413951 [TBL] [Abstract][Full Text] [Related]
16. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Rosell R; Gatzemeier U; Betticher DC; Keppler U; Macha HN; Pirker R; Berthet P; Breau JL; Lianes P; Nicholson M; Ardizzoni A; Chemaissani A; Bogaerts J; Gallant G Ann Oncol; 2002 Oct; 13(10):1539-49. PubMed ID: 12377641 [TBL] [Abstract][Full Text] [Related]
17. Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer. Sovak MA; Lutzker S; Zheng L; Guensch L; Joyce M; Schwartz S; Wu Y; Aisner J Lung Cancer; 2006 Aug; 53(2):177-81. PubMed ID: 16790293 [TBL] [Abstract][Full Text] [Related]
18. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial. Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer. Luo J; Leaw SJ; Xu Y; Zheng D Med Oncol; 2011 Dec; 28(4):1418-24. PubMed ID: 20661668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]